Litcius/Paper detail

Effect of GBCA Use on Detection and Diagnostic Performance of the Central Vein Sign: Evaluation Using a 3-T FLAIR* Sequence in Patients With Suspected Multiple Sclerosis

Lynn Daboul, Carly M. O’Donnell, Quy Cao, Moein Amin, Paulo Rodrigues, J. Andrew Derbyshire, Christina Azevedo, Amit Bar‐Or, Eduardo Caverzasi, Peter A. Calabresi, Bruce Cree, Léorah Freeman, Roland G. Henry, Erin E. Longbrake, Kunio Nakamura, Jiwon Oh, Nico Papinutto, Daniel Pelletier, Rohini Samudralwar, Suradech Suthiphosuwan, Matthew K. Schindler, Elias S. Sotirchos, Nancy L. Sicotte, Andrew Solomon, Russell T. Shinohara, Daniel S. Reich, Daniel Ontaneda, Pascal Sati

2022American Journal of Roentgenology20 citationsDOIOpen Access PDF

Abstract

The postcontrast FLAIR* sequence should be considered for CVS evaluation in future investigational trials and clinical practice.

Topics & Concepts

MedicineFluid-attenuated inversion recoveryRadiologyNuclear medicineMultiple sclerosisImaging biomarkerMagnetic resonance imagingPsychiatryMultiple Sclerosis Research StudiesCerebral Venous Sinus ThrombosisUltrasound and Hyperthermia Applications
Effect of GBCA Use on Detection and Diagnostic Performance of the Central Vein Sign: Evaluation Using a 3-T FLAIR* Sequence in Patients With Suspected Multiple Sclerosis | Litcius